CIK: 0001232621 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 15, 2016
Total Value ($000): $224,444 (89.4% shares, 10.6% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 6,197,198 | $111,860 | 49.8% | $13.95 | +40.0% | COM | 427746102 |
| — | LA JOLLA PHARMACEUTICAL CO | 3,052,130 | $48,834 | 21.8% | $14.80 | — | COM | 503459604 |
| — | IGNYTA INC | 3,972,800 | $21,533 | 9.6% | $5.43 | — | COM | 451731103 |
| — | OPKO HEALTH INC | 14,000,000 | $19,753 | 8.8% | $1.47 | — | DEBT 3.0% 2/1/33 | 68375NAB9 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 90,215 | $7,019 | 3.1% | $62.32 | +36.4% | COM | 09061G101 |
| BABA | ALIBABA GROUP HOLDING LIMITED | 60,000 | $4,772 | 2.1% | $79.03 | — | SPONSORED ADS | 01609W102 |
| — | MERRIMACK PHARMACEUTICALS INC | 3,500,000 | $3,965 | 1.8% | $1.36 | — | NOTE 4.5% 7/15/20 | 590328AA8 |
| — | NEKTAR THERAPEUTICS | 260,000 | $3,700 | 1.6% | $13.75 | — | COM | 640268108 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 430,000 | $1,221 | 0.5% | $4.43 | -29.9% | COM | 09058V103 |
| — | LIPOCINE INC | 260,000 | $790 | 0.4% | $5.77 | — | COM | 53630X104 |
| — | ATYR PHARMA INC | 279,425 | $777 | 0.3% | $3.57 | — | COM | 002120103 |
| — | CELLDEX THERAPUETICS INC | 50,000 | $220 | 0.1% | $3.78 | — | COM | 15117B103 |